Showing results (171-180 of 207) with videos related to
Sort By:
Pageof 21
Oncogene|December 23, 2014
SYK interaction with ITGβ4 suppressed by Epstein-Barr virus LMP2A modulates migration and invasion of nasopharyngeal carcinoma cellsX Zhou, L Matskova, L-S Z Rathje, et al.Hepatology (Baltimore, Md.)|March 3, 2021
An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United StatesRobert J Wong, Carol L Brosgart, Sue Welch, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2005
T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infectionKiyoaki Ito, Yasuhito Tanaka, Etsuro Orito, et al.Journal of Viral Hepatitis|September 29, 2016
Community-based real-world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United StatesR J Wong, M T Nguyen, H N Trinh, et al.Gut|March 13, 2021
Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatmentMan-Fung Yuen, Danny Ka-Ho Wong, Thomas Schluep, et al.Journal of Virological Methods|May 22, 2003
Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase supportHideaki Kato, Etsuro Orito, Fuminaka Sugauchi, et al.Hepatology Communications|June 22, 2023
Advancing research, awareness, screening, and linkage to care to eliminate HDV in the U.SMegan Glynn, Chari Cohen, Robert G Gish, et al.Journal of Hepatology|July 15, 2024
Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtideMaria Buti, Heiner Wedemeyer, Soo Aleman, et al.Gastroenterology|August 9, 2005
Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registryKris V Kowdley, David J Brandhagen, Robert G Gish, et al.Gastroenterology|November 7, 2007
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis BRobert G Gish, Anna S Lok, Ting-Tsung Chang, et al.Pageof 21